Dermalax Plus (1×1.1ml)

Avoid alcohol for 24h before and 48h after the procedure. Alcohol acts as a vasodilator and blood thinner, which can significantly increase post-injection swelling and worsen bruising in the highly vascular periorbital and perioral areas.

The formulation contains 20 mg/ml of monophasic cross-linked Hyaluronic Acid and 0.3% Lidocaine hydrochloride. It is supplied with high-quality 30G needles for precision work.

Dosage is individualized based on the depth of the lines and the target area. Typically, 0.5 ml to 1.1 ml (one syringe) is used per session. Practitioners should evaluate if 0.5 ml of filler is sufficient for localized touch-ups around the eyes or mouth. For superficial use, it is often compared to the soft integration properties of Restylane Kysse when used for mucosal hydration.

Common reactions include temporary redness, minor swelling, and localized purple bruising at the entry points. These effects generally resolve within 3 to 7 days. To ensure an optimal recovery, patients should follow our expert aftercare guide. Any immediate blanching or persistent pain must be addressed according to protocols for signs of vascular occlusion.

The gel acts by physically filling the superficial to mid-dermis, providing immediate mechanical smoothing of fine lines. Its monophasic structure allows it to integrate seamlessly with the surrounding tissue, mimicking the skin's natural hydration. This is a targeted approach compared to general skin boosters, as it provides enough structural stability to maintain a wrinkle-free surface for up to a year.

Treatment is strictly contraindicated. No clinical safety data exists for the use of Dermalax fillers during pregnancy or breastfeeding. We prioritize maternal health and recommend deferring all elective aesthetic injections until after the nursing period has concluded.